Cornerstone Pharmaceuticals initiates phase I clinical trial of CPI-613 for the treatment of metastatic colorectal cancer

Press/Media: Press / Media

PeriodJan 14 2015

Media coverage

1

Media coverage

  • TitleCornerstone Pharmaceuticals initiates phase I clinical trial of CPI-613 for the treatment of metastatic colorectal cancer
    Media name/outletMedical News Today
    CountryUnited Kingdom
    Date1/14/15
    PersonsAngela Alistar